Last news
From a Simple Idea to a Global Standard: EV Blocks Founder Wins Global Entrepreneur of the Year 2025

From a Simple Idea to a Global Standard: EV Blocks Founder Wins Global Entrepreneur of the Year 2025

What started as a frustration on site has become a global product. PETERBOROUGH, England, Dec. 9, 2025 /PRNewswire/ -- EV Blocks is proud to share that founder Trevor Palmer has been named Global Entrepreneur of the Year 2025 at The Allica Bank...

With Child Deaths Projected to Rise for the First Time in a Century, Gates Foundation and Mohamed Bin Zayed Foundation for Humanity Urge Action as World Faces Critical Turning Point

With Child Deaths Projected to Rise for the First Time in a Century, Gates Foundation and Mohamed Bin Zayed Foundation for Humanity Urge Action as World Faces Critical Turning Point

At Goalkeepers Abu Dhabi, global leaders outline a path to improve and save the lives of millions of children through lifesaving innovation and renewed investment Partners announce $1.9 billion to advance polio eradication Event held in partnership...

EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide

EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide

PROVIDENCE, R.I., Dec. 9, 2025 /PRNewswire/ -- EpiVax, Inc., with U.S. Food and Drug Administration (FDA) and CUBRC, Inc. (Buffalo, NY) scientist collaborators, announces the publication of a study titled "Immunogenicity Risk Assessment of...

Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as well as in both metastatic and early stage breast cancer. FLORENCE, Italy and NEW YORK,...

Abracon Strengthens Global Supply Chain and Quick-Turn Capabilities to Support Growing MEMS Oscillator Demand

Abracon Strengthens Global Supply Chain and Quick-Turn Capabilities to Support Growing MEMS Oscillator Demand

AUSTIN, Texas, Dec. 9, 2025 /PRNewswire/ -- Abracon, a leading provider of timing, frequency control, power, magnetics, RF, and antenna solutions, has announced significant enhancements to its global operations to meet the rising demand for its MEMS...

Bybit Institutional Sets the Stage for 2026 at High-Profile Abu Dhabi Gala

Bybit Institutional Sets the Stage for 2026 at High-Profile Abu Dhabi Gala

DUBAI, UAE, Dec. 9, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, hosted its BIG Series – Bybit Institutional Gala in Abu Dhabi, bringing together key Bybit executives, global regulators, banking...

GameChange BOS Surpasses Orders for 190 Transformers as New Manufacturing Facility Ramps Up

GameChange BOS Surpasses Orders for 190 Transformers as New Manufacturing Facility Ramps Up

NORWALK, Conn., Dec. 9, 2025 /PRNewswire/ -- GameChange BOS, a division of GameChange Energy, announced that it has surpassed orders for 190 medium-voltage transformers, marking a major milestone for the company's expanding product line. The...

Employers Across APME Signal Intentional Growth as Hiring Outlook Improves to +31% for Q1 2026: Latest ManpowerGroup Employment Outlook Survey

Employers Across APME Signal Intentional Growth as Hiring Outlook Improves to +31% for Q1 2026: Latest ManpowerGroup Employment Outlook Survey

The Net Employment Outlook (NEO) for Q1 2026 in Asia Pacific and the Middle East (APME) stands at +31%. With an NEO of +38%, the Information sector and Finance & Insurance sector leads hiring intentions, followed by Tech & IT Services...

menu
menu